2
Orphan Designations
0
FDA Approvals
4
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| Hodgkins lymphoma | fixed set of four ribonucleic acid lipoplex (RNA-LPX) drug products (RBL001.3, RBL002.4, RBL003.3, RBL004.3) which code for four melanoma tumor-associated antigens | Orphan Designation | - |
| small cell lung carcinoma | a recombinant bispecific antibody composed of the light chains and heavy chains of the anti-VEGF-A antibody bevacizumab, fused with an anti-PD-L1 single domain antibody to the C-terminus of its heavy chain via a stable linker (G4S)2G | Orphan Designation | - |
| stage II endometrioid carcinoma | fixed set of four ribonucleic acid lipoplex (RNA-LPX) drug products (RBL001.3, RBL002.4, RBL003.3, RBL004.3) which code for four melanoma tumor-associated antigens | Orphan Designation | - |
| stage IVb bladder cancer | fixed set of four ribonucleic acid lipoplex (RNA-LPX) drug products (RBL001.3, RBL002.4, RBL003.3, RBL004.3) which code for four melanoma tumor-associated antigens | Orphan Designation | - |